Fundraising Fox
/Companies
Sign in

Cellective BioTherapy

Research Triangle Park, US · Founded 2015 · Delaware corporation

Find your way into Cellective BioTherapy

Sign up to see every warm intro you have to Cellective BioTherapy

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellective BioTherapy team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cellective Biotherapy develops regulatory B10 cell-based immunotherapies designed to enhance or inhibit immune responses for treating cancers, autoimmunity, immunodeficiency, and infectious disease. Its pipeline focuses on first-in-class B cell-directed therapies.

BiotechHealthtech

Founders & leadership

Cellective BioTherapy was founded in 2015 by Thomas F. Tedder.

TF
Thomas F. TedderFounder
RB
Robert BonczekNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2015

▶$2.5MraisedMay 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BonczekExecutive Officer, Director, Promoter
  • Thomas F. TedderExecutive Officer, Director, Promoter
Offering amount
$2.5M
Amount sold
$2.5M
First sale
May 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cellective BioTherapy do?
Cellective Biotherapy develops regulatory B10 cell-based immunotherapies designed to enhance or inhibit immune responses for treating cancers, autoimmunity, immunodeficiency, and infectious disease. Its pipeline focuses on first-in-class B cell-directed therapies.
Who founded Cellective BioTherapy?
Cellective BioTherapy was founded by Thomas F. Tedder in 2015.
How much funding has Cellective BioTherapy raised?
Cellective BioTherapy has disclosed $2.5M raised across 1 round.
Where is Cellective BioTherapy headquartered?
Cellective BioTherapy is headquartered in Research Triangle Park, US.